glp 1 gpcr GLP-1R and Diabetes GLP-1R, GIPR and GCGR Cell
Description
GLP-1s should be avoided in anyone with a personal or family history of MTC or MEN2 (Multiple Endocrine Neoplasia Type 2)
The formulations are functionally identical
Retatrutide is given as a once-weekly subcutaneous injection using a pen injector, typically into the arm, thigh, or abdomen similar to Mounjaro and Wegovy
And semaglutide (Ozempic) now carries an indication for diabetic nephropathy
Here are a few other articles to check out about GLP-1 medications: Note: Some GLP-1s are approved by the Food and Drug Administration (FDA) to help with weight loss management
Translational Psychiatry 10(1)
